Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Nocebo response in Parkinson's disease: A systematic review and meta-analysis.

Leal Rato M, Duarte GS, Ferreira AN, Alves M, Mainoli B, Teodoro T, Mestre TA, Costa J, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Apr 20. pii: S1353-8020(19)30210-X. doi: 10.1016/j.parkreldis.2019.04.015. [Epub ahead of print] Review.

PMID:
31103487
2.

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

Fabbri M, Zibetti M, Ferrero G, Accornero A, Guimaraes I, Rizzone MG, Romagnolo A, Ferreira JJ, Lopiano L.

Parkinsonism Relat Disord. 2019 Apr 28. pii: S1353-8020(19)30213-5. doi: 10.1016/j.parkreldis.2019.04.018. [Epub ahead of print]

PMID:
31060986
3.

MDS evidence-based review of treatments for essential tremor.

Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee.

Mov Disord. 2019 Jul;34(7):950-958. doi: 10.1002/mds.27700. Epub 2019 May 2. Review.

PMID:
31046186
4.

Corrigendum to "Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis" [Arch. Gerontol. Geriatr. 81 (March-April) (2019) 209-214].

Caldeira D, Nunes-Ferreira A, Rodrigues R, Vicente E, Pinto FJ, Ferreira JJ.

Arch Gerontol Geriatr. 2019 Jul - Aug;83:338. doi: 10.1016/j.archger.2019.04.008. Epub 2019 Apr 26. No abstract available.

PMID:
31036372
5.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
6.

Proper or Improper Use of the Crossover Design in Clinical Trials in Chronic Sciatica?

Leal Rato M, Duarte GS, Ferreira JJ.

JAMA Neurol. 2019 Apr 29. doi: 10.1001/jamaneurol.2019.0870. [Epub ahead of print] No abstract available.

PMID:
31034000
7.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Mar 2. pii: S1353-8020(19)30089-6. doi: 10.1016/j.parkreldis.2019.02.043. [Epub ahead of print]

PMID:
30902528
8.

Morphine in acute coronary syndrome: systematic review and meta-analysis.

Duarte GS, Nunes-Ferreira A, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J, Caldeira D.

BMJ Open. 2019 Mar 15;9(3):e025232. doi: 10.1136/bmjopen-2018-025232.

9.

Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis.

Caldeira D, Alves D, Costa J, Ferreira JJ, Pinto FJ.

PLoS One. 2019 Feb 20;14(2):e0211228. doi: 10.1371/journal.pone.0211228. eCollection 2019.

10.

Integrating genetic and physical positions of the anthracnose resistance genes described in bean chromosomes Pv01 and Pv04.

Murube E, Campa A, Ferreira JJ.

PLoS One. 2019 Feb 14;14(2):e0212298. doi: 10.1371/journal.pone.0212298. eCollection 2019.

11.

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P.

Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25.

12.

Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.

Caldeira D, Nunes-Ferreira A, Rodrigues R, Vicente E, Pinto FJ, Ferreira JJ.

Arch Gerontol Geriatr. 2019 Mar - Apr;81:209-214. doi: 10.1016/j.archger.2018.12.013. Epub 2018 Dec 27. Erratum in: Arch Gerontol Geriatr. 2019 Jul - Aug;83:338.

PMID:
30612074
13.

Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Camporeze B, Manica BA, Bonafé GA, Ferreira JJC, Diniz AL, de Oliveira CTP, Mathias Junior LR, de Aguiar PHP, Ortega MM.

Am J Cancer Res. 2018 Oct 1;8(10):1900-1918. eCollection 2018. Review.

14.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

15.
16.

Genetic diversity assessed by genotyping by sequencing (GBS) and for phenological traits in blueberry cultivars.

Campa A, Ferreira JJ.

PLoS One. 2018 Oct 23;13(10):e0206361. doi: 10.1371/journal.pone.0206361. eCollection 2018.

17.

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.

Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.

Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.

PMID:
30347489
18.

Oxytocin can regulate myometrial smooth muscle excitability by inhibiting the Na+ -activated K+ channel, Slo2.1.

Ferreira JJ, Butler A, Stewart R, Gonzalez-Cota AL, Lybaert P, Amazu C, Reinl EL, Wakle-Prabagaran M, Salkoff L, England SK, Santi CM.

J Physiol. 2019 Jan;597(1):137-149. doi: 10.1113/JP276806. Epub 2018 Nov 22.

PMID:
30334255
19.

Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.

Fabbri M, Rosa MM, Ferreira JJ.

Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2. Review.

PMID:
30318555
20.

Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions.

Rato ML, Duarte GS, Mestre T, de Carvalho M, Ferreira JJ.

Lancet Neurol. 2018 Oct;17(10):842. doi: 10.1016/S1474-4422(18)30310-7. Epub 2018 Sep 18. No abstract available.

PMID:
30264722

Supplemental Content

Loading ...
Support Center